APA (7th ed.) Citation

JE, S., L, H., DE, D., CL, K., E, B., Z, H., . . . NB, H. (2024). The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 78(1), 217. https://doi.org/10.1093/cid/ciad534

Chicago Style (17th ed.) Citation

JE, Schuster, et al. "The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 78, no. 1 (2024): 217. https://doi.org/10.1093/cid/ciad534.

MLA (9th ed.) Citation

JE, Schuster, et al. "The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 78, no. 1, 2024, p. 217, https://doi.org/10.1093/cid/ciad534.